Oxytocin News and Research RSS Feed - Oxytocin News and Research

New study shows women susceptible to pain-relieving placebo effect of vasopressin

New study shows women susceptible to pain-relieving placebo effect of vasopressin

A new study in the current issue of Biological Psychiatry suggests that women are particularly susceptible to the pain-relieving placebo effect of vasopressin. [More]
Higher oxytocin in pregnancy predicts severity of postpartum depression symptoms

Higher oxytocin in pregnancy predicts severity of postpartum depression symptoms

Higher oxytocin levels in the third trimester of pregnancy predicts the severity of postpartum depression symptoms in women who previously suffered from depression, reports a new Northwestern Medicine study. [More]
Study examines depressed mother's oxytocin levels and mother-child emotional bonding

Study examines depressed mother's oxytocin levels and mother-child emotional bonding

Widely referred to as the "love" hormone, oxytocin is an indispensable part of childbirth and emotional mother-child bonding. Psychologists at Florida Atlantic University are conducting a novel study to determine how a mother's levels of oxytocin might be different in women with depression. [More]
Love hormone may enhance compassion of people suffering from PTSD symptoms

Love hormone may enhance compassion of people suffering from PTSD symptoms

Oxytocin - "the love hormone" - may enhance compassion of people suffering from symptoms of post-traumatic stress disorder (PTSD), according to new study conducted at the University of Haifa and Rambam Health Care Campus: "The fact that the present study found, that Oxytocin may improvement compassion among patients with post-traumatic stress disorder toward women, provides new evidence that oxytocin may be able to improve the social behavior of these patients," said Professor Simone Shamay-Tsoory from the Department of Psychology at the University of Haifa, who led the study. [More]
Study shows bromances can improve men’s health, reduce stress

Study shows bromances can improve men’s health, reduce stress

Male friendships, portrayed and often winked at in bromance movies, could have healthful effects similar to those seen in romantic relationships, especially when dealing with stress, according to a new study of male rats by researchers at the University of California, Berkeley. [More]
UTHealth researchers demonstrate new way to reduce preterm birth

UTHealth researchers demonstrate new way to reduce preterm birth

Using nanoparticles to engineer a special drug, a team of researchers from McGovern Medical School at The University of Texas Health Science Center at Houston has demonstrated in pre-clinical trials a new way to both reduce preterm birth and avoid the risks of medication in pregnancy to unborn babies. [More]
Researchers demonstrate new way to reduce preterm birth using nanoparticles

Researchers demonstrate new way to reduce preterm birth using nanoparticles

Using nanoparticles to engineer a special drug, a team of researchers has demonstrated in mice a new way to both reduce preterm birth and avoid the risks of medication in pregnancy to unborn babies. [More]
Turing Pharmaceuticals emphasizes continued availability of Daraprim

Turing Pharmaceuticals emphasizes continued availability of Daraprim

Turing Pharmaceuticals AG, a privately-held biopharmaceutical company focused on developing and commercializing innovative treatments for serious diseases and conditions, today emphasizes the continued availability of Daraprim and cautions healthcare providers of proposed alternatives to Daraprim. [More]
Oxytocin hormone strengthens social ties

Oxytocin hormone strengthens social ties

Nowadays, much emphasis is placed on sustainability. The degree to which people are willing to donate their own money for this depends on their level of oxytocin. Scientists at the University of Bonn Hospital have discovered that the willingness to donate increases with the quantity of this bonding hormone. However, oxytocin only has an effect with regard to social sustainability projects. The hormone does not increase the ability to participate in the case of purely environmentally oriented projects. [More]
Maternal mortality down 44% since 1990

Maternal mortality down 44% since 1990

Maternal mortality has fallen by 44% since 1990, United Nations agencies and the World Bank Group reported today. [More]
New report highlights progress made in preventable maternal deaths

New report highlights progress made in preventable maternal deaths

Maternal mortality has fallen by 44% since 1990, United Nations agencies and the World Bank Group reported today. [More]
Oxytocin treatment improves social, emotional and behavioral problems among young kids with autism

Oxytocin treatment improves social, emotional and behavioral problems among young kids with autism

A five week treatment with the synthetic hormone oxytocin significantly improved social, emotional and behavioral issues among young children with autism, according to University of Sydney research published today in Molecular Psychiatry. [More]
Love hormone may enhance pleasure of social interactions, UCI study finds

Love hormone may enhance pleasure of social interactions, UCI study finds

The hormone oxytocin, which has been associated with interpersonal bonding, may enhance the pleasure of social interactions by stimulating production of marijuana-like neurotransmitters in the brain, according to a University of California, Irvine study. [More]
Controlling TH-containing neurons can manipulate maternal behavior of females and aggression of males

Controlling TH-containing neurons can manipulate maternal behavior of females and aggression of males

Most female mammals give birth and care for their offspring, while the males often breed with multiple partners and play little role in parenting once the mating is over. Yet researchers have had a hard time pinpointing where, exactly, in the brain these differences between the sexes are located and how they translate into behavior. The extent of "hardwired parental behavior" is hotly disputed. [More]
Philip Chapper & Co to showcase new partner products at Europe’s largest pharmaceutical trade fair

Philip Chapper & Co to showcase new partner products at Europe’s largest pharmaceutical trade fair

Philip Chapper & Company Ltd, a UK company with over 40 years’ experience within medical supplies, is to showcase innovative products from new suppliers at the industry’s largest European trade fair. [More]
Research examines effects of antidepressant use on health of mother and child

Research examines effects of antidepressant use on health of mother and child

The use of antidepressants during pregnancy has no long term neurodevelopmental or behavioural effects on the child, however they may be associated with an increased risk of postpartum haemorrhage, suggests the findings from three studies published in BJOG: An International Journal of Obstetrics and Gynaecology (BJOG). [More]
Fetal microchimerism could be a subtle and dizzyingly complex puzzle

Fetal microchimerism could be a subtle and dizzyingly complex puzzle

Parents go to great lengths to ensure the health and well-being of their developing offspring. The favor, however, may not always be returned. [More]
UiO researchers test new nasal spray device for treating mental illness

UiO researchers test new nasal spray device for treating mental illness

Researchers at the University of Oslo have tested a new device for delivering hormone treatments for mental illness through the nose. This method was found to deliver medicine to the brain with few side effects. [More]
Turing Pharmaceuticals acquires rights to market Daraprim (pyrimethamine) in the U.S.

Turing Pharmaceuticals acquires rights to market Daraprim (pyrimethamine) in the U.S.

Turing Pharmaceuticals AG today announced that it has acquired the exclusive rights to market Daraprim (pyrimethamine) in the U.S. from Impax Laboratories, Inc. The acquisition by Turing is part of a strategic effort focused on treatments for toxoplasmosis and other serious infectious diseases. The company also announced plans to invest in the development of new drug candidates for toxoplasmosis. [More]
Turing Pharmaceuticals completes $90 million Series A financing

Turing Pharmaceuticals completes $90 million Series A financing

Turing Pharmaceuticals AG, a privately-held biopharmaceutical company focused on discovering and developing treatments for serious and life-threatening diseases, today announced the completion of its Series A financing. The $90 million round was led by Martin Shkreli, Founder & Chief Executive Officer. [More]
Advertisement
Advertisement